Cold agglutinin disease (acute haemolysis)
Haemolytic anaemia · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Autoimmune haemolysis from cold-reactive (usually IgM) antibodies agglutinating red cells at low temperatures, causing acrocyanosis and complement-mediated haemolysis. Primary or secondary to infection (mycoplasma, EBV) or lymphoma.
Red flags
- Rapidly falling haemoglobin / haemodynamic compromise
- Haemoglobinuria
- Cold exposure precipitating crisis
Assessment
Differential diagnosis
- Warm autoimmune haemolytic anaemia
- Paroxysmal cold haemoglobinuria
- Microangiopathic haemolysis (TTP/HUS)
- Raynaud phenomenon
Investigations
- FBC and blood film (agglutination, spherocytes), reticulocytes
- Direct antiglobulin test (positive for C3d), cold agglutinin titre
- LDH (raised), haptoglobin (low), bilirubin
- Screen for underlying infection/lymphoproliferative disorder
Management
- Keep the patient warm (including limbs, environment and any IV fluids/blood)
- Treat any underlying trigger (infection, lymphoma)
- Transfuse only if necessary, using a blood warmer and warmed products
- For significant primary disease: consider rituximab-based therapy
- Avoid steroids/splenectomy as first line (less effective than in warm AIHA)
Drugs & doses
Warming measures and warmed IV fluids/blood
Rituximab (mainstay for treatment-requiring primary disease)
Complement inhibition (e.g. sutimlimab) in specialist settings
Folic acid supplementation
Disposition
Admit for significant haemolysis; haematology involvement and treatment of any underlying cause.
Complications & pitfalls
- Severe anaemia
- Acrocyanosis/tissue ischaemia
- Transfusion difficulties from agglutination
Exam pearls
- Keeping the patient warm is a key intervention - including warming transfused blood and IV fluids.
- Corticosteroids and splenectomy are much less effective than in warm AIHA; rituximab is preferred.
- Cross-matching is difficult due to agglutination - liaise closely with the blood bank.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.